Page results
-
The Neurometabolic unit provides a unique range of investigations and clinical laboratory advice encompassing mitochondrial, neurotransmitter, pterin and amino acid disorders.
-
The clinical management of neuromuscular muscle wasting diseases such as motor neuron disease, myasthenia gravis, muscular dystrophy and peripheral neuropathy.
-
Typically, patient care is multidisciplinary led by consultant neuro-ophthalmologists and neurologists.
-
The department is responsible for a wide range of neurophysiological procedures, principally electromyography (EMG) and nerve conduction studies, EMG-guided botulinum toxin (BoTox) injections, electroencephalography (EEG), evoked potentials (EPs) and intra-operative monitoring (IOM)
-
The plasma exchange service at the National Hospital treats patients with neuroimmunological diseases such as Guillain-Barré syndrome and myasthenia gravis.
-
Mindfulness patient information.
-
We provide a specialist spinal surgery service including treatment of degenerative spinal conditions, artificial discs, spinal injury, spinal tumours (intra and extra dural, including metastatic disease), scoliosis and syringomyelia.
-
AutoLab is a dual haematology and biochemistry laboratory which operates as a public private partnership between Sonic Healthcare pty (The Doctors Laboratory) and UCLH NHS Foundation Trust Hospitals Laboratories.
-
Autoimmune serology is provided for: Connective tissue diseases, Endocrine diseases, Liver diseases, Rheumatic diseases, Skin diseases, Thyroid diseases.
-
The department has a special interest in sexually transmitted viral infections and viral infections in relation to hepatitis, bone marrow transplants and HIV-related viral resistance.
File results
-
FOI/2023/0260 - Treatment for rare diseases: Fabry, Gaucher and Pompe disease and Hunter Syndrome
-
FOI/2023/0332 - Eating disorder services and Advance Decisions/ Directives to refuse medical treatment (ADRTs)
-
FOI/2023/0262 - Clinical trial participation
-
FOI/2023/0275 - Trust statistics on spiking
-
FOI/2019/16 Antenatal unit questionnaire
-
FOI2017320 Patients with Multiple Sclerosis treated with MS disease modifying drugs
-
FOI2017300 Sustainability and transformation
-
FOI2017315 Expenditure on reconciliation and validation of incomplete and missing RTT codes
-
FOI/2023/0242 - Treatment of Haemophilia A
-
FOI2017328 Use of variable rate intravenous insulin infusion